Search Results 201-210 of 18211 for creatine evidence

1. CA 125 test - Mayo Clinic

   And no evidence shows that this screening decreases the chance of dying of ovarian cancer. An elevated level of CA 125 could prompt your healthcare ...

2. IgA nephropathy (Berger disease) - Diagnosis and treatment - Mayo Clinic

   If you have kidney disease, blood tests might show higher levels of the waste product creatinine or the protein cystatin C. Kidney biopsy. This procedure is ...

3. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors - Mayo Clinic

   ... evidence of metastatic disease. Acceptable scans are multiphase computed ... Serum creatinine ≤ 1.5 x institutional ULN (within 28 days prior to registration); ...

4. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   Histological evidence of definite NASH. Based on NASH Clinical Research ... Estimated creatinine clearance <30 mL/min; Current use of the following ...

5. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

   Evidence of end-organ damage that can be ... Renal insufficiency: serum creatinine >2mg/dL ... Have serum creatinine ≤3 times the upper limit of normal ...

6. Belantamab, Lenalidomide, and Daratumumab for Newly-diagnosed Multiple Myeloma - Mayo Clinic

   Calculated creatinine clearance ≥ 30 ml/min using the Cockcroft-Gault formula below: Creatinine ... Evidence of current clinically significant uncontrolled ...

7. A Study to Evaluate Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant - Mayo Clinic

   BUN ≤ 40 mg/dl; creatinine ≤ 2.0 mg/dl . ... Renal: BUN ≤ 40 mg/dl; creatinine ≤ mg/dl; Hepatic: INR ... Evidence of metastatic disease. Presence of a ...

8. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

   Have no evidence of new or enlarging brain metastases; and; Are not using steroids ≤ 14 days prior to registration. Known leptomeningeal disease. Co-morbid ...

9. Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma - Mayo Clinic

   Part 2: Molecular evidence of BAP1 loss of function ... evidence of loss of function by gene sequencing ... Creatinine < 2.0 × ULN; Hepatic function ...

10. A Multicenter Treatment Protocol Of Daclatasvir (BMS-790052) In Combination With Sofosbuvir For The Treatment Of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    Clinical or pathologic evidence of acute ongoing liver graft rejection; Creatinine clearance (CrCl) ≤30 mL/min (as estimated by Cockcroft and Gault formula) ...